Literature DB >> 12644895

Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH.

Sandra Holt1, Christopher J Fowler.   

Abstract

The metabolism of anandamide by fatty acid amidohydrolase (FAAH) at different intra- and extracellular pH values has been investigated in intact C6 rat glioma cells. The cellular uptake of anandamide at 37 degrees C was found to decrease by 28% when the extracellular pH (pH(e)) was reduced from pH 7.4 to pH 6.2. In contrast, a selective decrease in intracellular pH (pH(i)), accomplished by acidifying the cells followed by incubation in sodium-free buffer at pH 7.4, did not affect the uptake. Anandamide uptake was inhibited by (R)-ibuprofen, with pI(50) values of 3.05+/-0.57, 3.66+/-0.23 and 3.94+/-0.88 at pH(e) values of 7.4, 6.8 and 6.2, respectively. In the presence of phenylmethylsulfonyl fluoride, however, (R)-ibuprofen failed to inhibit the uptake of anandamide. A reduction in pH(e) from 7.4 to 6.2 produced a 17% reduction in the FAAH-catalyzed metabolism of anandamide in the intact C6 cells. However, an increased sensitivity of FAAH activity to inhibition by (R)-ibuprofen as well as (R,S)-flurbiprofen and (S)-flurbiprofen was seen at a lower pH(e). For (R)-ibuprofen, pI(50) values of 3.57+/-0.08, 4.04+/-0.05 and 4.59+/-0.04 were found at pH(e) values of 7.4, 6.8 and 6.2, respectively. For (R,S)- and (S)-flurbiprofen, the pI(50) values at pH(e) 7.4 were 4.02+/-0.05 and 4.13+/-0.18, respectively at a pH(e) of 7.4, and 4.81+/-0.11 and 4.84+/-0.10, respectively, at a pH(e) of 6.2. In contrast, intracellular acidification did not affect either the rate of anandamide metabolism or its inhibition by (R)-ibuprofen or (S)-flurbiprofen. It is concluded that a reduction of extracellular pH produces an enhanced accumulation of the acidic NSAIDs ibuprofen and flurbiprofen into C6 glioma cells and thereby an inhibition of anandamide metabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644895     DOI: 10.1007/s00210-002-0686-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  40 in total

1.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Authors:  B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

2.  Distribution and characterization of anandamide amidohydrolase in mouse brain and liver.

Authors:  K Watanabe; H Ogi; S Nakamura; Y Kayano; T Matsunaga; H Yoshimura; I Yamamoto
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

3.  Tissue and intracellular pH in normal periarticular soft tissue and during different phases of antigen induced arthritis in the rat.

Authors:  S E Andersson; K Lexmüller; A Johansson; G M Ekström
Journal:  J Rheumatol       Date:  1999-09       Impact factor: 4.666

4.  Plasma levels after peroral and topical ibuprofen and effects upon low pH-induced cutaneous and muscle pain.

Authors:  A E Steen; P W Reeh; G Geisslinger; K H Steen
Journal:  Eur J Pain       Date:  2000       Impact factor: 3.931

Review 5.  Cannabinoids and pain.

Authors:  A S Rice
Journal:  Curr Opin Investig Drugs       Date:  2001-03

Review 6.  The palmitoylethanolamide family: a new class of anti-inflammatory agents?

Authors:  Didier M Lambert; Severine Vandevoorde; Kent-Olov Jonsson; Christopher J Fowler
Journal:  Curr Med Chem       Date:  2002-03       Impact factor: 4.530

Review 7.  Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides.

Authors:  M P Patricelli; B F Cravatt
Journal:  Vitam Horm       Date:  2001       Impact factor: 3.421

8.  Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.

Authors:  L De Petrocellis; T Bisogno; J B Davis; R G Pertwee; V Di Marzo
Journal:  FEBS Lett       Date:  2000-10-13       Impact factor: 4.124

9.  Sensitization to hyperthermia by intracellular acidification of C6 glioma cells.

Authors:  R Kitai; M Kabuto; T Kubota; H Kobayashi; H Matsumoto; S Hayashi; H Shioura; T Ohtsubo; K Katayama; E Kano
Journal:  J Neurooncol       Date:  1998-09       Impact factor: 4.130

10.  Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide.

Authors:  N Ueda; Y Kurahashi; S Yamamoto; T Tokunaga
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

View more
  10 in total

Review 1.  Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?

Authors:  Irmgard Tegeder; Gerd Geisslinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-04       Impact factor: 3.000

Review 2.  The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1.

Authors:  C J Fowler; P S Naidu; A Lichtman; V Onnis
Journal:  Br J Pharmacol       Date:  2009-02       Impact factor: 8.739

3.  Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.

Authors:  Christopher J Fowler; Emmelie Björklund; Aron H Lichtman; Pattipati S Naidu; Cenzo Congiu; Valentina Onnis
Journal:  J Enzyme Inhib Med Chem       Date:  2012-01-06       Impact factor: 5.051

Review 4.  Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

Authors:  May Hamza; Raymond A Dionne
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

5.  Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.

Authors:  A Lenman; C J Fowler
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

6.  Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.

Authors:  J Manzanares; Md Julian; A Carrascosa
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

7.  R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice.

Authors:  Katja Schmitz; Natasja de Bruin; Philipp Bishay; Julia Männich; Annett Häussler; Christine Altmann; Nerea Ferreirós; Jörn Lötsch; Alfred Ultsch; Michael J Parnham; Gerd Geisslinger; Irmgard Tegeder
Journal:  EMBO Mol Med       Date:  2014-11       Impact factor: 12.137

8.  Inhibition of endocannabinoid metabolism by the metabolites of ibuprofen and flurbiprofen.

Authors:  Jessica Karlsson; Christopher J Fowler
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

9.  Effect of α-tocopheryl succinate on the molecular damage induced by indomethacin in C6 glioma cells.

Authors:  Murat Pekmez; Evren Önay-Uçar; Nazli Arda
Journal:  Exp Ther Med       Date:  2014-12-03       Impact factor: 2.447

10.  Non-opioid Analgesics and the Endocannabinoid System

Authors:  Ruhan Deniz Topuz; Özgur Gündüz; Çetin Hakan Karadağ; Ahmet Ulugöl
Journal:  Balkan Med J       Date:  2020-06-19       Impact factor: 2.021

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.